Royal Bank Of Canada Forecasts Strong Price Appreciation for Acadia Healthcare (NASDAQ:ACHC) Stock

Acadia Healthcare (NASDAQ:ACHC) had its price target lifted by Royal Bank Of Canada from $17.00 to $28.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank Of Canada’s price target points to a potential upside of 19.45% from the company’s previous close.

A number of other equities research analysts have also recently issued reports on the company. Guggenheim dropped their price objective on Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating on the stock in a research note on Monday. Raymond James Financial set a $17.00 price target on shares of Acadia Healthcare in a research note on Wednesday, December 3rd. Mizuho lowered their price objective on shares of Acadia Healthcare from $22.00 to $17.00 and set a “neutral” rating on the stock in a research note on Thursday, December 18th. Jefferies Financial Group cut shares of Acadia Healthcare to a “hold” rating in a report on Thursday, January 22nd. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $20.69.

Acadia Healthcare Stock Up 5.2%

Shares of ACHC stock opened at $23.44 on Thursday. The firm’s fifty day moving average price is $14.82 and its two-hundred day moving average price is $18.57. The company has a current ratio of 1.55, a quick ratio of 1.44 and a debt-to-equity ratio of 1.27. Acadia Healthcare has a 1 year low of $11.43 and a 1 year high of $33.58. The firm has a market capitalization of $2.16 billion, a P/E ratio of -1.92, a PEG ratio of 7.67 and a beta of 0.89.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, February 25th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.04. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The company had revenue of $821.46 million during the quarter, compared to analysts’ expectations of $800.10 million. During the same quarter last year, the company earned $0.64 EPS. Acadia Healthcare’s revenue for the quarter was up 6.1% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. On average, equities analysts predict that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Allworth Financial LP boosted its holdings in shares of Acadia Healthcare by 676.4% during the second quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock worth $31,000 after acquiring an additional 1,177 shares during the period. EverSource Wealth Advisors LLC increased its position in shares of Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the period. Wells Fargo & Company MN lifted its position in Acadia Healthcare by 208.9% during the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after purchasing an additional 1,510 shares during the period. Bayforest Capital Ltd acquired a new stake in Acadia Healthcare during the fourth quarter worth about $52,000. Finally, Hantz Financial Services Inc. raised its position in shares of Acadia Healthcare by 501.9% in the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock valued at $54,000 after buying an additional 1,822 shares in the last quarter.

More Acadia Healthcare News

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Q4 revenue topped estimates and EPS beat consensus, driving a strong intraday jump; management provided FY2026 and Q1 2026 guidance that gave investors a clearer outlook. Acadia Healthcare’s (NASDAQ:ACHC) Q4 CY2025 Sales Top Estimates, Stock Jumps 10.8%
• Positive Sentiment: The company posted its Q4 earnings presentation and materials, helping investors parse revenue mix, margin drivers and the path to management’s FY26 targets. Acadia Healthcare Company, Inc. 2025 Q4 – Results – Earnings Call Presentation
• Positive Sentiment: Multiple brokerages raised price targets and maintain buy/outperform stances—RBC to $28 (outperform), UBS to $27 (buy) and TD Cowen to $24 (buy)—which increases buy-side conviction and likely supported the rally. Benzinga: Analyst Price-Target Updates
• Positive Sentiment: Analysts and commentary highlighted improving execution and embedded EBITDA opportunities under returning management, reinforcing the view that operational fixes could restore profitability. TipRanks: Buy Rating on Improving Execution
• Neutral Sentiment: Aggregated analyst coverage: a Benzinga deep-dive summarizes 17 analyst ratings and consensus perspectives — useful for context on how Street expectations are shifting but not a single catalyst. Acadia Healthcare Co Stock: A Deep Dive Into Analyst Perspectives (17 Ratings)
• Negative Sentiment: Short interest remains very large (~32.45M shares as of mid‑Feb, ~35.9% of float) with a ~7.3 days-to-cover ratio — this high short position increases the risk of volatile trading, squeezes, or pressure if execution disappoints. (short-interest reports summarized in filings and market data)

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.